Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor

Overview of attention for article published in International Journal of Nanomedicine, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,676 followers.

https://t.co/jCwXfRNjMi

27 Oct 2021

Reply Repost Favourite

New article: Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor https://t.co/mLXD8E0e1R #melanoma #oncology https://t.co/Lqb0S3UXtg

22 Apr 2021

Reply Repost Favourite

" Notably, CRM1 is overexpressed in a broad spectrum of cancers, and its overexpression is often an indicator of poor prognosis.8–10 CRM1 is additionally reported to mediate drug resistance in various contexts.11,12 We have propose…https://t.co/O3gZTxRESA

20 Apr 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.